When PDD and VPD groups were divided into three sub-groups based on UPDRS-III scores respectively, we found serum TFF3 levels were significantly lower in VPD patients than those in PDD patients in UPDRS(III)≤30 and 31<UPDRS(III)<50 sub-groups. Here, TFF3 is linked to velopharyngeal dysfunction.